688393.SSShanghai
Guangzhou LBP Medicine Science & Technology Co., Ltd.
¥19.13
ListedAug 20, 2020
SectorHealthcare
IndustryMedical Instruments & Supplies
CountryChina
Employees-
State-| CityGuangzhou| AddressNo. 2, Kexin Street| Phone86 20 3229 9997
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner. It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment. The company was founded in 2005 and is based in Guangzhou, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
0.0
?
Div. Rate
¥0.10
?
Div. Yield
0.43%
?
Payout Ratio
750.00%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.43
?
Div. Growth Rate
25.00%
?
Score
72

Dividend History

Historical dividend payments by ex-dividend date.

May 29, 2025
¥ 0.1000
May 29, 2024
¥ 0.1500
May 25, 2023
¥ 0.1400
May 18, 2022
¥ 0.2700
May 28, 2021
¥ 0.2800

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!